What is the standard sliding scale (SS) insulin regimen for managing hyperglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Standard Sliding Scale Insulin Regimen for Hyperglycemia Management

The sole use of sliding scale insulin (SSI) in the inpatient hospital setting is strongly discouraged and should not be used as the primary method for managing hyperglycemia. 1

Preferred Insulin Regimens Over SSI

A basal-bolus insulin regimen is the preferred treatment approach for managing hyperglycemia in hospitalized patients, rather than sliding scale insulin alone. This approach includes:

  • For patients with good nutritional intake:

    • Basal insulin (long-acting): 50% of total daily dose
    • Prandial insulin (rapid-acting): 50% of total daily dose divided before meals
    • Correction insulin as needed 1
  • For patients with poor oral intake or NPO status:

    • Basal insulin plus correction doses (basal-plus approach) 1
    • Starting total daily insulin dose: 0.3-0.5 units/kg for insulin-naive patients 1
    • Lower doses (0.1-0.25 units/kg) for patients at higher risk of hypoglycemia (elderly, renal failure, poor oral intake) 1

When Sliding Scale Insulin Might Be Appropriate

While generally discouraged, sliding scale insulin alone may be appropriate in limited circumstances:

  • Patients without diabetes who have mild stress hyperglycemia 1
  • Patients with HbA1c <7% or normal blood glucose on dietary management or low-dose oral agents 1
  • Patients with mild hyperglycemia who are NPO with no nutritional replacement 1

Reasons to Avoid Sliding Scale Insulin Alone

  • Associated with clinically significant hyperglycemia 1
  • Higher mean blood glucose levels compared to basal-bolus regimens 2
  • Increased incidence of hyperglycemic events 2
  • Does not provide basal insulin coverage 3
  • Reactive rather than proactive approach to glucose management

Blood Glucose Targets

  • Target blood glucose range: 140-180 mg/dL (7.8-10.0 mmol/L) for most hospitalized patients 1
  • More stringent targets (110-140 mg/dL) may be appropriate for selected patients if achievable without significant hypoglycemia 1

Example of Standardized Correction Insulin Scale

When correction insulin is needed as part of a basal-bolus regimen, a standardized approach with different intensity levels based on insulin sensitivity is recommended:

Blood Glucose (mg/dL) Low-Dose Scale Moderate-Dose Scale High-Dose Scale
140-180 1 unit 2 units 3 units
181-220 2 units 4 units 6 units
221-260 3 units 6 units 9 units
261-300 4 units 8 units 12 units
>300 5 units 10 units 15 units

Monitoring and Adjustment

  • Check blood glucose before meals and at bedtime for patients who are eating 4
  • Check every 4-6 hours for NPO patients 4
  • Adjust insulin doses based on patterns of glycemic control 4
  • Implement a hypoglycemia management protocol to prevent and treat low blood glucose 1

Important Cautions

  • Never use sliding scale insulin alone in patients with type 1 diabetes 1
  • Avoid premixed insulin therapy in the hospital due to high risk of hypoglycemia 1
  • Reduce total daily insulin dose by approximately 20% for patients on higher doses at home (≥0.6 units/kg/day) to prevent hypoglycemia during hospitalization 1

By following these evidence-based recommendations, hyperglycemia can be managed more effectively while reducing the risks associated with outdated sliding scale insulin regimens.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Addressing hyperglycemia from hospital admission to discharge.

Current medical research and opinion, 2010

Guideline

Glycemic Management in Critically Ill Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.